Global Drug-Coated Balloons Market Revenue and Share Analysis Through 2029

Uncover key drivers, emerging technologies, and competitive movements shaping the drug-coated balloons market from 2025–2034 with trusted insights from The Business Research Company

What Is The Projected Valuation Of The Drug-Coated Balloons Market In The Period 2029-2034?

The drug-coated balloons market has demonstrated substantial growth in recent years. This market is anticipated to expand from $1.08 billion in 2024 to $1.24 billion in 2025, at a compound annual growth rate (CAGR) of 14.6%. Historically, this growth can be attributed to an increased burden of cardiovascular disease, a rising demand for minimally invasive procedures, the prevalence of peripheral artery disease (PAD), efforts to reduce restenosis rates, and advancements in interventional cardiology.

The drug-coated balloons market is anticipated to experience substantial expansion over the upcoming years. Its value is projected to reach $2.2 billion by 2029, achieving a compound annual growth rate (CAGR) of 15.5%. This expansion during the prediction period is largely driven by factors such as a rising elderly demographic, broader indications and uses, an emphasis on outpatient and ambulatory treatments, incorporation of advanced drug delivery systems, and worldwide health programs. Key developments expected within this timeframe encompass gaining regulatory clearance for novel compositions, an increased effort to reduce adverse effects, the advent of bioresorbable coatings, market penetration into developing nations, and strategies centered around patients.

Access A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=10829&type=smp

What Strategic Drivers Are Accelerating The Drug-Coated Balloons Market Expansion?

The increasing incidence of coronary artery disease is projected to drive the expansion of the drug-coated balloons market in the foreseeable future. Coronary artery disease (CAD) refers to a medical condition characterized by the constriction or blockage of the coronary arteries, which supply blood to the heart muscle, potentially resulting in heart attacks. A drug-coated balloon serves as a medical device for managing coronary artery disease, where medication is delivered into the artery during the procedure to aid in preventing restenosis, the recurrence of artery narrowing following angioplasty. As an illustration, a study from August 2022, published by the US-based Journal of the American College of Cardiology, predicted that all four major cardiovascular risk factors would see an increase within the general U.S. population between 2025 and 2060. Diabetes is expected to show the most significant percentage rise at 39.3%, with dyslipidemia increasing by 27.6%, hypertension by 25.1%, and obesity by 18.3%. The researchers additionally found that the highest projected increases in rates were for heart failure (33.4%) and ischemic heart disease (30.7%), followed by heart attack (16.9%) and stroke (33.8%). Consequently, the growing prevalence of coronary artery disease is anticipated to stimulate the drug-coated balloon market.

What Is The Detailed Segment Distribution Of The Drug-Coated Balloons Market?

The drug-coated balloonsmarket covered in this report is segmented –

1) By Product: Drug-Coated Balloons For Peripheral Artery Disease, Drug-Coated Balloons For Coronary Artery Disease, Drug-Coated Balloons For Other Indications

2) By Drug Type: Paclitaxel, Sirolimus

3) By End User: Hospitals, Cardiac Catheterization Labs, Ambulatory Surgical Centers

Subsegments:

1) By Drug-Coated Balloons For Peripheral Artery Disease: Paclitaxel-Coated Balloons, Sirolimus-Coated Balloons

2) By Drug-Coated Balloons For Coronary Artery Disease: Paclitaxel-Coated Balloons, Sirolimus-Coated Balloons, Everolimus-Coated Balloons

3) By Drug-Coated Balloons For Other Indications: Drug-Coated Balloons For Femoropopliteal Lesions, Drug-Coated Balloons For Renal Artery Lesions, Drug-Coated Balloons For Other Vascular Applications

How Are Global Trends Impacting The Development Of The Drug-Coated Balloons Market?

Product innovations are a key trend gaining popularity in the drug-coated balloon market. Major companies operating in the drug-coated balloon market are focused on developing new technological and innovative solutions to strengthen their position in the market. For instance, in August 2022, Becton, Dickinson, and Company (BD), a US-based medical technology company, launched the PREVISION first-in-human trial for a peripheral sirolimus drug-coated balloon (DCB). This trial aims to assess the safety and effectiveness of the sirolimus DCB in treating patients with peripheral artery disease, a condition that significantly impacts mobility and quality of life.

Who Are The Major Stakeholders Operating In The Drug-Coated Balloons Market?

Major companies operating in the drug-coated balloons market include Acotec Scientific AG, B. Braun Melsungen AG, Biosensors International Group Ltd, Medtronic Inc., Boston Scientific Corporation, Opto Circuits, Concept Medical, Cardionovum GmbH, Endocor GmbH, Hexacath Sverige, iVascular SLU, Minvasys SAS, MedAlliance, QT Vascular Ltd, Terumo Corporation, Biotronik, Cook Medical, Cordis Corporation, Abbott Laboratories, Surmodics Inc., Hexacath SAS, MicroPort, SurModics Inc., Orchestra BioMed

Download The Full Report Here:

https://www.thebusinessresearchcompany.com/report/drug-coated-balloons-global-market-report

Which Region Is Projected To Achieve The Fastest Growth In The Drug-Coated Balloons Market?

North America was the largest region in the global drug-coated balloons market in 2024, and is expected to be the fastest-growing region in the forecast period. The regions covered in the drug-coated balloons market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Get A Report Customized For You Here:

https://www.thebusinessresearchcompany.com/customise?id=10829&type=smp

Browse Through More Reports Similar to the Global Drug-Coated Balloons Market 2025, By The Business Research Company

Pta Balloon Catheter Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/pta-balloon-catheter-global-market-report

Tumor Necrosis Factor Inhibitor Drugs Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/tumor-necrosis-factor-inhibitor-drugs-global-market-report

Antispasmodics Drugs Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/antispasmodics-drugs-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795